HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]. [electronic resource]
Producer: 20060411Description: 18 p. digitalISSN:- 1471-2482
- Alanine Transaminase -- metabolism
- Aspartate Aminotransferases -- metabolism
- Clinical Protocols
- Cyclosporine -- adverse effects
- Cytoprotection -- drug effects
- Double-Blind Method
- Glycine -- administration & dosage
- Glycine Agents -- administration & dosage
- Kidney Diseases -- chemically induced
- Kupffer Cells -- drug effects
- Liver Transplantation -- mortality
- Multicenter Studies as Topic
- Postoperative Care
- Randomized Controlled Trials as Topic -- methods
- Reperfusion Injury -- diagnosis
- Research Design
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.